Hypoplastic Left Heart: Stage-I Will be Performed Interventionally, Soon

Area of Science:

• Pediatric Cardiology
• Congenital Heart Disease
• Interventional Cardiology

Background:

• Hypoplastic left heart syndrome (HLHS) presents significant variability and complexity.
• Current management involves individualized therapy, fetal interventions, and staged surgical palliation (Norwood/Hybrid, Fontan circulation).
• Existing treatments necessitate complex surgeries and intensive neonatal care.

Purpose of the Study:

• To explore alternative percutaneous transcatheter techniques for Stage-I management of HLHS.
• To reduce reliance on complex surgical procedures and neonatal intensive care.
• To advance non-surgical treatment options for single ventricle physiology.

Main Methods:

• Review of current fetal and neonatal interventions for HLHS.
• Discussion of catheter-based approaches including ductal stenting and atrial septum manipulation.
• Focus on developing a percutaneous transcatheter technique for a non-surgical Stage-I approach.

Main Results:

• Fetal interventions like maternal hyperoxygenation aim to improve left heart structures.
• Stage-I management typically involves Norwood/Sano surgery or the Hybrid approach.
• Advancements in catheter-based interventions are paving the way for less invasive options.

Conclusions:

• There is a growing focus on developing completely non-surgical Stage-I approaches for HLHS.
• Percutaneous transcatheter techniques offer a promising alternative to traditional surgical palliation.
• Minimizing complex surgeries and intensive care is a key goal for HLHS management.